论文部分内容阅读
萌蒂制药作为一家跨国的独立联营制药集团于1957年在瑞士成立,目前在美国、德国、英国设有联合科研机构,业务遍及全球数十个国家和地区。自1993年进入中国以来,萌蒂(中国)制药有限公司历经2006年由合资企业到独资公司蜕变,作为国内唯一一家专业研发生产和推广镇痛药的跨国制药企业一直致力于推动中国镇痛规范化治疗水平的发展。2011年1月萌蒂集团投资2000万美元,在北京亦庄建成并投入使用具有世界一流水准的萌蒂新工厂。萌蒂(中国)制药有限公司的产品美施康
As a multinational affiliate pharmaceutical group, Mengti Pharma was established in Switzerland in 1957 and currently has joint research institutes in the United States, Germany and the United Kingdom, and operates in dozens of countries and regions around the world. Since its entry into China in 1993, Mengdi (China) Pharmaceutical Co., Ltd. has been transformed from a joint venture to a wholly-owned company in 2006. As the only multinational pharmaceutical company specializing in the R & D, production and marketing of analgesics, it has been committed to promoting the standardization of pain relief in China Therapeutic level of development. January 2011 Mengti Group invested 20 million US dollars, built in Beijing Yizhuang and put into use a world-class Mengdi new plant. Meisi (China) Pharmaceutical Co., Ltd. products Meishi Kang